Saturday, 31 October 2026European Markets

SHELF DRILLING Stock Slides By 16% In The Last 5 Sessions

Loading stream...

(VIANEWS) - Shares of SHELF DRILLING (Oslo Børs Benchmark Index_GI: SHLF.OL) fell by a staggering 16.84% in 5 sessions from kr33.25 to kr27.65 at 19:39 EST on Wednesday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI is falling 3.74% to kr1,160.25, after five sequential sessions in a row of losses.

SHELF DRILLING's last close was kr29.50, 14.24% below its 52-week high of kr34.40.

About SHELF DRILLING

Shelf Drilling, Ltd., together with its subsidiaries, operates as a shallow water offshore drilling contractor in the Middle East, North Africa, the Mediterranean, Southeast Asia, India, and West Africa. The company offers equipment and services for the drilling, completion, maintenance, and decommissioning of oil and natural gas wells. It serves government owned or controlled energy companies, and publicly listed global integrated oil companies or independent exploration and production companies. As of December 31, 2021, it owned 30 independent-leg cantilever jack-up rigs. Shelf Drilling, Ltd. was incorporated in 2012 and is headquartered in Dubai, the United Arab Emirates.

Earnings Per Share

As for profitability, SHELF DRILLING has a trailing twelve months EPS of kr-16.75.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -19.14%.

More news about SHELF DRILLING (SHLF.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com